🇺🇸 FDA

Intelligence · Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≤24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months — use filters for patent-cliff planning.

Page 7 of 13

  1. US 9987242

    Treatment of Levodopa-induced Dyskinesias

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9980992

    Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9980976

    Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of glucocorticoid receptor agonists

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9981968

    Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9968642

    Compositions and methods for treatment of pain

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9962448

    Compounds and methods for targeted immune system delivery

    Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9951014

    Mammalian and bacterial nitric oxide synthase inhibitors

    Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9931333

    Compositions and methods for treating or preventing atrial fibrillation

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9931418

    Compositions for the delivery of RNA and drugs into cells

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9925213

    Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9907479

    Contribution of oxidative stress to AF electrograms

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9897595

    Compositions and methods for the detection of zinc

    Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9890117

    Benzamide compounds and related methods of use

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9889209

    Nanoconjugates able to cross the blood-brain barrier

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9878984

    Anti-cancer compounds

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9878996

    2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9862761

    Composition and method for preventing or treating a tauopathy

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9856231

    Tetrahydrothiophene-based GABA aminotransferase inactivators

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9844600

    Injectable thermoresponsive polyelectrolytes

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9844562

    Polyvalent RNA-nanoparticle compositions

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9839625

    Inhibition of cancer cell motility

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9802942

    Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9802946

    NMDA receptor modulators and uses thereof

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9801952

    Magnetic nanostructures as theranostic agents

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9796755

    Methods of treating depression and other related diseases

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9783855

    Cancer screening by detection of ultrastructural and molecular markers

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9783858

    Altered microbiome of chronic pelvic pain

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9783525

    Map kinase modulators and uses thereof

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9782428

    Method for generation of broadly neutralizing anti-pathogen antibodies

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9765055

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9757475

    Templated nanoconjugates

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9750845

    Biodegradable nanocomposites with enhanced mechanical properties for soft tissue engineering

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9725475

    Arsenoplatin anti-cancer agents

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9719089

    Nucleic acid functionalized nonoparticles for therapeutic applications

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9707281

    Pharmaceutical compositions and methods for digesting atherosclerotic plaques

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9701733

    Maspin-based treatment of cancer

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9701661

    2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9688637

    3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members

    Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9675607

    Epimorphic regeneration and related hydrogel delivery systems

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9677075

    Metal-ligand coordination polymer nanoparticles and methods for making

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9670141

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9669014

    Small molecule inhibitors of superoxide dismutase expression

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9663493

    Pyridazine compounds, compositions and methods

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9663468

    2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9655917

    Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9650421

    Self-assembled nanostructures

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9642805

    Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9636329

    Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.